Neuralink Unveils ‘Blindsight’ to Restore Vision for Blind, Secures FDA Approval
Elon Musk’s brain-chip company, Neuralink, has unveiled a new experimental device called Blindsight, aimed at restoring vision for the blind. The U.S. Food and Drug Administration (FDA) granted the device “breakthrough” status on September 17, placing it among the most advanced medical technologies designed to treat severe health conditions.